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Abstract Schwann cells (SCs) can be used to repair
both the peripheral and central nervous systems.
Therefore, establishment of a procedure to obtain
activated, highly proliferative SCs, in an appropriate
time for clinical applications, is a prerequisite. Purifi-
cation is complicated by contamination with fibro-
blasts which often become the predominant cell type in
an in vitro SC culture. This study describes a novel and
efficient method to enrich SCs by utilizing the differ-
ential detachment properties of the two cell types. In
culture, cells were treated with two different media and
the chelator, EGTA, which detached SCs faster than
fibroblasts and allowed for easy isolation of SCs.
Within seven days, high yields of SCs with a purity of
greater than 99% were achieved. This was confirmed
by immunostaining characterization and flow-cyto-
metric analyses using an antibody against the p75 low
affinity nerve growth factor receptor (p75LNGFR).
The entire procedure was completed in approximately
21 days. This method has the advantage of being
technically easier, faster, and more efficient than other
previously described methods. An SC culture that was
about 99% homogenous was achieved.
Keywords Sciatic nerve  Predegeneration 
Schwann cell  Detachment property 
Purification
Introduction
Schwann cells (SC) are the main glial cells of the
peripheral nervous system which can promote neural
regeneration by at least three routes: (i) an increase in
cell surface adhesion molecular synthesis (Ide 1996),
(ii) production of a basement membrane which
consists of extracellular matrix proteins (Rothblum
et al. 2004), and (iii) production of neurotrophic
factors and their corresponding receptors. SCs have
been extensively investigated for cell therapy in a
variety of CNS injury models, including the spinal
cord (Pearse et al. 2004; Barakat et al. 2005), brain
(Kromer and Cornbrooks 1985), and optic nerve
(Harvey et al. 1995). Moreover, autologous nerve
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grafting or biodegradable conduits are the gold
standard for peripheral nerve repair (Mackinnon and
Dellon 1990). In this category, an active area of
research involves the development of a biodegradable
conduit which contains SCs for the promotion of
axonal regeneration. Therefore, mass production of
pure SCs within a short period of time is a
prerequisite to achieving this aim.
Isolation and purification of SCs is usually a
complex process. This complexity is caused by
fibroblast contamination which is due to the higher
and faster proliferation rate of fibroblasts than SCs.
Two main approaches have been implemented for the
isolation of SCs: pre-degeneration (Keilhoff et al.
2000; Verdu et al. 2000; Vroemen and Weidner
2003) and intact nerve (Weinstein and Wu 1999). The
pre-degeneration approach results in a higher yield of
SCs relative to the intact nerve approach (Keilhoff
et al. 2000; Mauritz et al. 2004). However, to obtain
purified and homogenous SCs different modifications
to the pre-degeneration approach have been applied
which include: (i) antimitotic treatment such as the
arabinoside chlora toxin (Calderon-Martinez et al.
2002), (ii) a combination of antimitotic treatment and
antibody-mediated cytolysis which employs the use
of complements (Assouline et al. 1983), (iii) repeated
explantation methods (Oda et al. 1989; Morrissey
et al. 1995a, b), (iv) differential adhesion and
detachment methods (Mauritz et al. 2004; Pannunzio
et al. 2005; Jin et al. 2008), (v) immunoselective
methods (Manent et al. 2003; Vroemen and Weidner
2003), and (vi) serum tapering (Komiyama et al.
2003; Hedayatpour et al. 2007).
Each of these methods have disadvantages: the
need for special equipment, high cost, low cell yields,
utilization of antimitogens that are not clinically
acceptable, and requirement of long time for cell
growth. This study now introduces a simple, fast,
inexpensive, and efficient method that results in the
production of both homogenous and purified SC
enrichment.
Materials and methods
Cultivation of SCs
Nerve harvesting and predegeneration
All animal care and surgical processes were under-
taken in strict accordance with the approval of the
Institutional Review Board and Institutional Ethical
Committee of Royan Institute. Sciatic nerve frag-
ments with lengths of approx. 20–25 mm were taken
bilaterally from deeply anesthetized (ketamine 80
mg/kg and xylazine 7 mg/kg i.p.) adult Wistar rats
(average weight 200–250 g) under aseptic conditions
and transferred to a sterile work bench. Nerves, in a
sterile environment, were weighed and twice washed
in phosphate-buffer saline (PBS; Gibco) and the
epineurium was stripped off by fine forceps. A sterile
scalpel was utilized to cut the tissues into short
segments of 2–4 mm in length. The protocol of SC
isolation and purification was summarized in Fig. 1.
Sciatic nerve pieces were kept for 15 days for in vitro
predegeneration. To allow fibroblasts to migrate out
of the explants, we incubated them for 2 weeks in a
predegeneration solution comprised of DMEM sup-
plemented with 10% (v/v) fetal calf serum (FCS) and
1% (w/v) penicillin/streptomycin. Simultaneously, in
Fig. 1 Depiction of the various treatments used to purify SCs
in culture. In brief, after 2 weeks of predegeneration, sciatic
explants are dissociated and plated in DMEM ? 10% (v/v)
FCS onto laminin-coated tissue culture dishes for 24 h. For
next 5 days, The DMEM is replaced with MGM media to
promote SC proliferation and reduce fibroblast expansion.
Purification is fulfilled via EGTA treatment
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order to elevate SC proliferation, 2 lM forskolin, as a
SC specific mitogen, was added. The medium was
refreshed biweekly.
Dissociation and primary plating
Pre-degenerated adult rat sciatic nerves were
exposed to supplemented DMEM and an enzyme
mixture consisting of 0.125% collagenase Type IV
and 1.25 U dispase/ml at 37C and 5% CO2 for 20 h
(Mauritz et al. 2004). After incubation, the cell
mixture was recovered by centrifugation at 1,800 g/
w for 10 min at room temperature. The pellet was
subsequently resuspended in supplemented DMEM
and plated on to 2 lg laminin/ml (Sigma)-coated
dishes at 75,000 cells/cm2 for 24 h. Finally, the
media was changed with melanocyte growth medium
(PromoCell) to which 2 lM forskolin (Calbiochem),
10 ng FGF-2/ml (Sigma) and 5 lg bovine pituitary
extract/ml (BPE-26, Promocell) were added in order
to prevent fibroblast proliferation. As a control,
the media was changed with fresh supplemented
DMEM.
SC purification
Cells were purified at approximately 75% conflu-
ence, which occurred within 5 or 6 days post
plating. To enrich adult rat SCs, initially the dishes
were washed with 2 ml Ca2?- and Mg2?-free PBS
followed by 2 ml 1 mM EGTA (Sigma). The dishes
were agitated for 2–4 min to release rounded-up or
detaching cells. The detachment was monitored with
phase contrast microscopy. The suspension of
floating cells that consisted of mainly SCs were
collected into a centrifuge tube and centrifuged at
1,800 g/w for 10 min. After removal of the super-
natant, the pellet was resuspended and plated as
described.
Characterization of SCs
Morphology
SCs were marked as phase bright, bi-, tri- or
multipolar with a small cytoplasm to nucleus ratio
as seen under phase-contrast microscope; while
fibroblasts were identified by a much more flattened
polymorphic shape with larger rounded nuclei (Mor-
rissey et al. 1995a, b). The total cell numbers and
number of SCs were counted from six random fields
(magnification 109) with a phase-contrast micro-
scope) by two independent investigators.
Immunofluorescent staining
SCs were plated on laminin (5 lg/ml, Sigma) and
poly L-ornithine-(15 lg/ml, Sigma)-coated glass cov-
erslips. The cells were washed in PBS and fixed with
4% (v/v) paraformaldehyde (Sigma) in PBS for
30 min. Fixed cells were washed with PBS. Blocking
was carried out in a blocking buffer that consisted of
10% (v/v) goat serum and 1 mg BSA/ml in PBS for
1 h. Primary antibodies against p75 low affinity NGF
receptor (p75LNGFR, 1:500, Abcam; ab6172) were
applied in dilute buffer consisting of 3% (v/v) goat
serum and 1 mg BSA/ml in PBS at room temperature
for 2 h or overnight at 4C. Then cells were washed
and the secondary antibody, goat anti-mouse IgG
conjugated-fluorescein isothiocyanate (FITC, 1:50),
was applied for 45 min at 37C. Cells were counter-
stained with DAP I for 2 min and observed under
fluorescence microscope. For negative controls, the
primary antibody was excluded.
Flow-cytometry analysis
The harvested cells were analyzed on a FACS Cal-
ibur flow-cytometer (Becton-Dickinson, Germany)
directly after the staining procedure. Data were
processed with WinMDI 2.8 software. The percent-
age of SCs in various samples was determined by
measuring the fraction of p75LNGFR positive cells in
the fluorescence intensity dotplot as compared to the
total amount of intact cells. A histogram was
subsequently prepared. The percentage of putative
SCs among total cells was obtained based on three
independent experiments.
Purity and yield of SCs
The purity and cell yields were determined by flow
cytometry and cell counts with a hemocytometer
following trypsinization, respectively. Purity was
defined as percentage while yields were determined
as the mean of 106 cells per biopsy.
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Results
Net weight of sciatic nerve
The lengths of six sciatic nerve fragments varied
between 20 and 25 mm and their average weights
were 12 ± 3 mg.
Primary culture and SC enrichment
Figure 2a shows the phase-contrast image of sciatic
nerve explants following 2 weeks of in vitro prede-
generation. An average of 4.1 ± 0.71 9 106 cells/
biopsy were obtained from enzymatic digestion of the
two week cultures of predegenerated explants which
were resuspended in DMEM supplemented with 10%
(v/v) FCS (Table 1). The majority of suspended cells
adhered to laminin coated dishes within 24 h and
developed into two distinct shapes that represented
fibroblasts and SCs. Fibroblasts were characterized
by a flat and polymorphic shape with an ovoid
nucleus and blunt cytoplasmic processes; while SCs
were identified as having small, bright and bipolar or
tripolar cell characteristics (Fig. 2b). At this stage,
cellular purity was 64.3 ± 0.8% (Table 1). Following
replacement of the medium with MGM, the number
of fibroblasts substantially reduced (Fig. 2c). Since a
high percentage of fibroblasts were observed in the
control group, these cells were not used for further
characterization (data not shown). Following treat-
ment with EGTA, most bipolar and tripolar cells
rounded-up, detached, and were easily released;
whereas flat and polygonal-shaped cells did not show
these changes (Fig. 2d). Cells obtained from each
dish were collected and reseeded respectively into a
new laminin-coated dish (Fig. 2e). Seven days after
culture, predegeneration and enrichment; the purity
of SCs reached 99.3 ± 0.4 with a yield of 2 ± 0.3
9 106 cells/biopsy (Table 1). Figure 2f–h shows
cellular immunostaining and flow-cytometry, reveal-
ing greater than 99% positivity for p75LNGFR, a
marker of SCs.
Discussion
SCs are valuable for peripheral nerve repair as well as
for spinal cord injury or myelin defects. Therefore,
obtaining pure sources and large scale SC production
is a prerequisite. The main obstacle for purification of
SCs is fibroblast contamination. This study describes
an efficient laboratory procedure for purification and
production of SCs, however it is important to note
that this is not a comparative study.
Fig. 2 Purification of SCs and fluorescent immunostaining.
a Phase-contrast photomicrograph of sciatic nerve explants
after 2 weeks of in vitro predegeneration. b Culture with
DMEM. Fibroblasts (black arrows) can be morphologically
identified and are clearly differentiated from SCs (arrow head).
c Primary culture with MGM. d Remaining fibroblasts after
purification. e Population‘ of SCs after purification. f Immu-
nocytochemical identification of adult rat SCs by p75LNGFR
and counterstained by DAPI. g Higher magnification of an
immunofluorescent stained SC with anti-p75LNGFR. h Histo-
gram by flow-cytometry for p75LNGFR positive SCs
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To increase SC yield, the predegeneration method
was used. In vivo and in vitro pre-degeneration of
peripheral nerves presents a convenient and effective
method to obtain activated SCs and an enhanced cell
yield when compared to untreated nerves (Mauritz
et al. 2004). The yield, purity, and proliferation rate
of SCs increases upon exposure to heregulin/for-
skolin during the two week predegeneration process
(Casella et al. 1996). Therefore, in this study, we also
implemented this procedure.
The new approach implemented in this study
involved the use of differential detachment time
windows between SCs and fibroblasts during expo-
sure to EGTA, in order to purify primary cultures.
The key point to this approach is the use of a suitable
extracellular matrix (ECM). An ideal matrix allows
for differential separation of SCs from fibroblasts.
Therefore, in this study we tested various concentra-
tions of laminin and poly-L-ornithine as ECMs, which
have been suggested in previous studies. Our obser-
vation revealed that implementation of 2 lg laminin/
ml led to a higher purification as compared to poly-L-
ornithine or the combination of both.
Cell seeding density is an important factor in
purification efficiency since at a high cell density,
SCs will adhere to fibroblasts. The cell density
implemented in this study was 75,000 cells/cm2,
which was lower than previously reported and did not
allow intermingling of fibroblast with SCs.
Another factor implemented in this procedure was
the use of media that allowed for differential cell
proliferation. SCs proliferate faster than fibroblasts in
the first 48 h, but after 72 h fibroblasts are the
dominating cell type in cultures, overlapping onto
SCs. To overcome this problem, DMEM was
exchanged with MGM which has been designed to
reduce fibroblast proliferation while maintaining
melanocyte proliferation. In addition, MGM miti-
gates the SCs process, thus reducing the adhesion of
SCs to ECM which aids in their isolation during
EDTA treatment. Culturing SCs in the absence of
serum lead to detachment of these cells which
allowed the cells to undergo anoikis or cell detach-
ment and death. For this reason, a minimum of 2.5%
(v/v) serum was added to DMEM. This has been a
common approach for maximizing SC proliferation
and minimizing fibroblast expansion, according to the
literature (Komiyama et al. 2003; Hedayatpour et al.
2007). One innovation of the presented method is that
if this enrichment method (DMEM with 2.5% serum)
were implemented, the SCs would adhere firmly
amongst proliferative fibroblasts and we would have
been unable to use the EGTA treatment for further
isolation. The only drawback in the use of good
manufacturing practice (GMP) is the presence of
bovine pituitary extract in its supplement, which can
be replaced by an animal-free product.
Morphological observation in conjunction with
cellular characterization showed that greater than
99% purification of SCs can be obtained by following
this procedure. Similar results have been reported
when the cold jet approach (Mauritz et al. 2004) or
collagenase NB (Jin et al. 2008) were used as
detachment methods. However when we imple-
mented the cold jet procedure in our initial setup,
we were unable to obtain a high purification yield.
In conclusion, our study shows that the use of
differential detachment properties of SCs against
fibroblasts could be considered to be one of the
procedures for obtaining a large quantity of homog-
enous SCs within a plausible time frame.
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